RB and its derivatives in solution exhibited cytotoxic activity against cancer cells [17,19]; for the treatment of hepatocellular cancer, RB in solution has also received approval from the US Food and Drug Administration [20]. The gene discussed is RB1; the disease is hepatocellular carcinoma.